Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
Weight loss drugs continue to make headlines. A new study conducted by researchers from the University of Southern ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
Weight loss drugs may also help reduce alcohol cravings, according to a new study. But you shouldn't use them to help curb ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback